Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 17,768 | 12,138 | 11,584 | 13,970 | 13,389 |
| Income taxes - deferred | -161 | -3,122 | -3,119 | 953 | -1,339 |
| Accounts receivable | -19,766 | 15,157 | -12,549 | -3,379 | -9,189 |
| Accounts payable and accrued liabilities | 4,016 | -10,013 | 38,721 | -9,468 | 9,420 |
| Other Working Capital | -11,386 | 12,987 | -11,527 | -12,208 | -10,992 |
| Other Operating Activity | 19,692 | -6,895 | -19,440 | 11,601 | 3,727 |
| Operating Cash Flow | $10,163 | $20,252 | $3,670 | $1,469 | $5,016 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -410 | -620 | -343 | -460 | -374 |
| Net Acquisitions | -3,196 | -106,885 | N/A | N/A | N/A |
| Purchase Of Investment | -3,853 | -7,053 | -6,964 | -36,656 | -46,789 |
| Sale Of Investment | 4,614 | 24,014 | 42,761 | 55,680 | 60,361 |
| Purchase Sale Intangibles | -2,401 | -24,508 | -3,328 | -515 | -1,671 |
| Other Investing Activity | 3,840 | 13,758 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,406 | $-101,294 | $32,126 | $18,049 | $11,527 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 109,394 | 1,809 | 543 | 1,638 |
| Debt Repayment | -5,010 | -55,881 | -2,708 | -7,965 | -3,036 |
| Common Stock Repurchased | 0 | -6 | -3,345 | -5,150 | -2,474 |
| Other Financing Activity | -899 | -2,695 | -455 | -2,782 | -55 |
| Financing Cash Flow | $-5,909 | $50,812 | $-4,699 | $-15,354 | $-3,927 |
| Exchange Rate Effect | 1,212 | -4,109 | 952 | 2,187 | 332 |
| Beginning Cash Position | 77,816 | 112,155 | 80,106 | 73,755 | 60,807 |
| End Cash Position | 81,876 | 77,816 | 112,155 | 80,106 | 73,755 |
| Net Cash Flow | $2,848 | $-30,230 | $31,097 | $4,164 | $12,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,163 | 20,252 | 3,670 | 1,469 | 5,016 |
| Capital Expenditure | -2,811 | -25,128 | -3,701 | -1,075 | -2,045 |
| Free Cash Flow | 7,352 | -4,876 | -31 | 394 | 2,971 |